Evidence map›Paper›PMID 35294616›Full record

ArticleJournal of neurology2022

Description of the first Spanish case of Gerstmann-Sträussler-Scheinker disease with A117V variant: clinical, histopathological and biochemical characterization.

Hasier Eraña, Beatriz San Millán, Carlos M Díaz-Domínguez, Jorge M Charco, Rosa Rodríguez, Irene Viéitez, Arrate Pereda, Rosa Yañez, Mariví Geijo, Carmen Navarro and 3 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Hasier Eraña *Prion Research Lab, Basque Research and Technology Alliance (BRTA), Center for Cooperative Research in Biosciences (CIC BioGUNE), Derio, Spain.ORCID http://orcid.org/0000-0001-8776-4211
Beatriz San Millán *Grupo de Enfermedades Raras y Medicina Pediátrica, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Vigo, Spain.ORCID http://orcid.org/0000-0002-1620-1283
Carlos M Díaz-DomínguezPrion Research Lab, Basque Research and Technology Alliance (BRTA), Center for Cooperative Research in Biosciences (CIC BioGUNE), Derio, Spain.ORCID http://orcid.org/0000-0002-0410-1963
Jorge M CharcoPrion Research Lab, Basque Research and Technology Alliance (BRTA), Center for Cooperative Research in Biosciences (CIC BioGUNE), Derio, Spain.ORCID http://orcid.org/0000-0003-3476-1855
Rosa RodríguezServicio de Neurología, Complejo Hospitalario de Ourense, Ourense, Spain.
Irene ViéitezGrupo de Enfermedades Raras y Medicina Pediátrica, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Vigo, Spain.ORCID http://orcid.org/0000-0001-9241-0207
Arrate PeredaMolecular (Epi)Genetics Laboratory, Araba University Hospital, Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0002-5442-7873
Rosa YañezServicio de Neurología, Complejo Hospitalario de Ourense, Ourense, Spain.
Mariví GeijoAnimal Health Department, NEIKER-Instituto Vasco de Investigación y Desarrollo Agrario, Basque Research and Technology Alliance (BRTA), Derio, Spain.ORCID http://orcid.org/0000-0002-3120-1038
Carmen NavarroGrupo de Enfermedades Raras y Medicina Pediátrica, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Vigo, Spain.ORCID http://orcid.org/0000-0003-4445-8585
Guiomar Perez de NanclaresMolecular (Epi)Genetics Laboratory, Araba University Hospital, Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0002-2424-5294
Susana TeijeiraGrupo de Enfermedades Raras y Medicina Pediátrica, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Vigo, Spain. Susana.Teijeira.Bautista@sergas.es.ORCID http://orcid.org/0000-0002-2092-5006
Joaquín CastillaPrion Research Lab, Basque Research and Technology Alliance (BRTA), Center for Cooperative Research in Biosciences (CIC BioGUNE), Derio, Spain. jcastilla@cicbiogune.es.ORCID http://orcid.org/0000-0002-2216-1361
CIC bioGUNE · ESComplejo Hospitalario de Ourense · ESHospital Universitario Araba · ESIkerbasque · ESInstituto de Investigación de Enfermedades Raras · ESNEIKER, the Basque Institute for Agricultural Research and Development · ES

Funding

Interreg POCTEFA EFA148/16Ministerio de Ciencia, Innovación y Universidades RTI2018-098515-B-I00
6 · The paper itself

Abstract

Gerstmann-Sträussler-Scheinker disease (GSS) is a rare neurodegenerative illness that belongs to the group of hereditary or familial Transmissible Spongiform Encephalopathies (TSE). Due to the presence of different pathogenic alterations in the prion protein (PrP) coding gene, it shows an enhanced proneness to misfolding into its pathogenic isoform, leading to prion formation and propagation. This aberrantly folded protein is able to induce its conformation to the native counterparts forming amyloid fibrils and plaques partially resistant to protease degradation and showing neurotoxic properties. PrP with A117V pathogenic variant is the second most common genetic alteration leading to GSS and despite common phenotypic and neuropathological traits can be defined for each specific variant, strikingly heterogeneous manifestations have been reported for inter-familial cases bearing the same pathogenic variant or even within the same family. Given the scarcity of cases and their clinical, neuropathological, and biochemical variability, it is important to characterize thoroughly each reported case to establish potential correlations between clinical, neuropathological and biochemical hallmarks that could help to define disease subtypes. With that purpose in mind, this manuscript aims to provide a detailed report of the first Spanish GSS case associated with A117V variant including clinical, genetic, neuropathological and biochemical data, which could help define in the future potential disease subtypes and thus, explain the high heterogeneity observed in patients suffering from these maladies.

Indexed as

Gerstmann-Straussler-Scheinker DiseasePrionsAmyloidHumansMutationPlaque, AmyloidAmyloidPrionsGerstmann–Sträussler–Scheinker diseaseInherited prion diseaseNeurodegenerationNeuropathologyPrion diseaseTransmissible spongiform encephalopathy

Identifiers

PMID35294616
PMCPMC9293843
OpenAlexW4221066421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.